Fig. 2
From: BRCA2 germline mutation carrier with five malignancies: a case report
Copy number variations. Blue, amplification or gain; red, loss; purple, loss of heterozygosity (LOH); grey, not covered by Oncoscan. (a) Well-differentiated liposarcoma of the right thigh, 2006; (b) clear cell renal cell carcinoma, 2008; (c) poorly differentiated invasive ductal breast carcinoma, 2010; (d) therapy-associated myeloproliferative neoplasia of primary myelofibrosis type, 2018; (e) breast carcinoma, no special type (NST), 2021